Literature DB >> 9552786

The use of 5% lidocaine for prolonged analgesia in chronic pain patients: a new technique.

Y K Choi1, J Liu.   

Abstract

BACKGROUND AND OBJECTIVES: It has been found that 5% lidocaine with 7.5% dextrose causes irreversible conduction block in animal studies. Our case report subjects allowed us to observe the efficacy of 5% lidocaine for a prolonged analgesia in vivo.
METHOD: After performing a diagnostic nerve block with 1% lidocaine, 5% lidocaine with 7.5% dextrose was injected into three patients with trigeminal neuralgia, post-herpetic occipital neuralgia, and intercostal neuralgia, respectively. The patients were followed for one and a half years. Visual Analog Scale (VAS) scores and the side effects were recorded for each patient.
RESULTS: One patient received a trigeminal block and one patient received an occipital nerve block. Both patients reported immediate and complete pain relief lasting 14 and 8 months, respectively. One patient, given an intercostal nerve block, received immediate pain relief lasting 5 weeks. None of these patients exhibited any appreciable side effects or complications.
CONCLUSIONS: Our observations suggest that 5% lidocaine may be used safely and effectively for the purpose of prolonged analgesia in selected patients with intractable chronic pain syndromes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9552786     DOI: 10.1016/s1098-7339(98)90118-3

Source DB:  PubMed          Journal:  Reg Anesth Pain Med        ISSN: 1098-7339            Impact factor:   6.288


  3 in total

1.  Presentation of Neurolytic Effect of 10% Lidocaine after Perineural Ultrasound Guided Injection of a Canine Sciatic Nerve: A Pilot Study.

Authors:  David D Kim; Asma Asif; Sandeep Kataria
Journal:  Korean J Pain       Date:  2016-07-01

Review 2.  Management strategies for the treatment of neuropathic pain in the elderly.

Authors:  Mahmood Ahmad; Charles Roger Goucke
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

3.  Prolongation of greater occipital neural blockade with 10% lidocaine neurolysis: a case series of a new technique.

Authors:  David Daewhan Kim; Nabil Sibai
Journal:  J Pain Res       Date:  2016-09-29       Impact factor: 3.133

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.